T. Rowe Price Associates’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-4,500	Closed	-$87K	–	2582
2014 Q2	$87K	Hold	4,500	–	–	﹤0.01%	2472
2014 Q1	$81K	Buy	4,500 +1,167	+35%	+$21K	﹤0.01%	2451
2013 Q4	$35K	Buy	+3,333	New	+$35K	﹤0.01%	2472